Similarly, integrated metabolomic–transcriptomic analyses have linked cuproptosis-associated genes (FDX1, DLAT, LIAS) with immunotherapy outcomes in cancers such as melanoma, lung cancer, and hepatocellular carcinoma. Here, FDX1 is linked to melanoma.